Related Experiment Video
Updated: Aug 16, 2026
Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
Published on: September 4, 2011
The KISS1 metastasis suppressor: mechanistic insights and clinical utility
1Department of Pathology, The National Foundation for Cancer Research, Center for Metastasis Research, University of Alabama, Birmingham, AL 35294-0019, USA.
Abstract:
Melanoma is a highly metastatic cancer that accounts for the majority of skin cancer deaths. Unfortunately, very few improvements have been made during the last 20 years in the management of melanoma metastases, which is the major cause of melanoma deaths. Therefore, identification of molecular targets that can be exploited in the clinic to treat metastatic disease is desperately needed. The KISS1 metastasis suppressor gene has emerged as a promising molecular target for the management of metastatic disease. This review compiles data regarding the molecular and biochemical properties of KISS1 and its cognate receptor, focusing on the properties believed to be most pertinent to the use of KISS1 in the clinical setting. In addition, clinical data that supports KISS1 as having a dual role as a prognostic indicator and a therapeutic target for the management of metastatic disease will be highlighted.
Insights
The KISS1 gene shows promise for treating metastatic melanoma, a leading cause of cancer deaths. Research highlights its potential as both a prognostic indicator and a therapeutic target for this aggressive skin cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma is a deadly skin cancer with high metastasis rates.
- Current treatments for metastatic melanoma have seen limited progress over the past two decades.
- There is a critical need for novel molecular targets to manage advanced melanoma.
Purpose of the Study:
- To review the molecular and biochemical characteristics of the KISS1 gene and its receptor.
- To evaluate the clinical relevance of KISS1 for managing metastatic melanoma.
- To highlight KISS1's potential as a prognostic biomarker and therapeutic target.
Main Methods:
- Literature review of scientific data on KISS1 and its receptor.
- Analysis of molecular and biochemical properties of KISS1.
- Compilation and assessment of clinical data related to KISS1 in melanoma.
Main Results:
- The KISS1 gene and its receptor possess properties pertinent to clinical applications in melanoma.
- Clinical data suggests KISS1 plays a dual role in melanoma progression.
- KISS1 functions as a prognostic indicator and a potential therapeutic target.
Conclusions:
- The KISS1 gene represents a promising target for the clinical management of metastatic melanoma.
- Further investigation into KISS1's therapeutic potential could lead to improved patient outcomes.
- KISS1's dual role offers new avenues for melanoma treatment strategies.
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...